Invest

Polumiros Inc.’s lead product is ReFilx™, a soft tissue filler for the permanent restoration of breast tissue defects in breast cancer patients post lumpectomy. This product will not only improve the quality of life and survivorship for breast cancer patients but also has a great potential to improve oncological outcomes. Please join us in this venture as we bring ReFilx™ to market and improve patient lives.

Quick Facts

Sector: Implanted Medical Devices

Product: ReFilx, a soft tissue filler for the permanent restoration of breast tissue defects.

Market Size: $3.3 Billion by 2019

Development Stage: Pre-Clinical Testing

Funds Raised: $0.28 Million in non-dilutive funding

Funding: Seeking $1.5 Million in seed funding

profits-1953616_1920